Prevention of perinatal herpes: Prophylactic antiviral therapy?

Clinical Obstetrics and Gynecology

Volumn 42, Issue 1, 1999, Pages 134-148

  Scott, L Laurie ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; VALACICLOVIR;

DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HERPES; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; PERINATAL INFECTION; PREGNANCY; RECURRENCE RISK; REVIEW; RISK BENEFIT ANALYSIS; VIRUS SHEDDING;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HERPES GENITALIS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VALINE; VIRUS SHEDDING;

EID: 0033376920     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199903000-00018     Document Type: Review

References (53)

1. Fleming D, McQuillan G, Johnson R, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997; 337:1105-1111.
2. Prober CG, Corey L, Brown ZA, et al. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis. 1992;15:1031-1038.
3. Benedetti J, Corey L, Ashley RL, et al. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994;121:847-854.
4. Benedetti J, Zeh J, Selke S, Corey L. Frequency and reactivation of nongenital lesions among patients with genital herpes simplex virus. Am J Med. 1995;98:237-242.
5. Whitley RJ, Arvin AM, Prober CG, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med. 1991;324:444-449.
6. Whitley RJ, Corey L, Arvin AM, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis. 1988;158:109-116.
7. Nahmias A, Alford CA, Korones SB. Infection in the newborn with herpes virus hominis. Adv Pediatr. 1970;17:185-226.
8. Whitley RJ, Arvin AM, Prober CG, et al. Predictors of morbidity in neonates with herpes simplex virus infections. N Engl J Med. 1991;324:450-454.
9. Nahmias A, Josey W, Naib Z, Freeman M, Fernandez R, Wheeler J. Significance of herpes simplex virus infection during pregnancy. Clin Obstet Gynecol. 1972;125: 929-938.
10. Stone K, Brooks CA, Guinan ME, Alexander ER. National surveillance for neonatal herpes simplex virus infections. Sex Trans Dis. 1989;16:152-156.
11. Nahmias A, Josey W, Naib Z, Freeman M, Fernandez R, Wheeler J. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol. 1971;110:825-837.
12. Nahmias A, Roizman B. Infection with herpes-simplex viruses 1 and 2 (second of three parts). N Engl J Med. 1973;289:719-725.
13. Brown ZA, Benedetti J, Ashley RL, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med. 1991; 324:1247-1252.
14. Prober CG, Hensleigh PA, Boucher F, Yasukawa L, Au D, Arvin AM. Use of viral cultures at delivery to identify neonates exposed to herpes simplex virus. N Engl J Med. 1988;318:887-891.
15. American College of Obstetricians and Gynecologists. Perinatal herpes simplex virus infections. ACOG Technical Bulletin 122. Washington DC: American College of Obstetricians and Gynecologists, 1988.
16. Sweet RL, Gibbs RS. Herpes virus infection. In: Sweet RL, Gibbs RS, eds. Infectious Diseases of the Female Genital Tract. Baltimore, MD: Williams and Wilkins, 1990.
17. Yeager A, Arvin AM, Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics. 1984; 73:188-193.
18. Roberts SW, Cox SM, Dax J, Wendel GD, Leveno KJ. Genital herpes during pregnancy: No lesions, no caesarean. Obstet Gynecol. 1995;85:261-264.
19. Arvin AM, Hensleigh PA, Prober CG, et al. Failure of antepartum maternal cultures to predict the infants risk of exposure to herpes simplex virus at delivery. N Engl J Med. 1986;315:796-800.
20. Prober CG. Herpetic vaginitis. Clin Obstet Gynecol. 1993;36:177-187.
21. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: Clinical manifestations, course, and complications. Ann Intern Med. 1983;98: 958-972.
22. Koelle DM, Benederti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med. 1992;116:433-437.
23. Brock B, Selke S, Benederti J, Douglas J, Corey L. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA. 1990;263:418-420.
24. Straus S, Seidlin M, Takiff H, et al. Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes. Sex Trans Dis. 1989; 16:107-113.
25. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologie characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med. 1995;333:770-775.
26. Randolph AG, Washington AE, Prober CG. Caesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs. JAMA. 1993;270:77-82.
27. Brown ZA, Baker DA. Acyclovir therapy during pregnancy. Obstet Gynecol. 1989; 73:526-531.
28. Glaxo Wellcome. Acyclovir pregnancy registry and valacyclovir pregnancy registry interim report, June 1, 1984-December 31, 1997. Glaxo Wellcome Inc. Worldwide Epidemiology.
29. Hintz M, Connor JD, Spector SA, Blum MR, Kenney RE, Yeager A. Neonatal acyclovir pharmacokinetics in patients with herpes virus infections. Am J Med. 1982; 73:210-214.
30. Yeager, A. Use of acyclovir in premature and term neonates. Am J Med. 1982;73: 205-209.
31. McDonald LK, Corey L, Mendelman PM, Opheim KE. Lack of toxicity in two cases of neonatal acyclovir overdose. Pediatr Infect Dis J. 1989;8:529-532.
32. Frenkel LM, Brown ZA, Bryson YJ, et al. Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol. 1991;164:569-576.
33. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med. 1996;124:8-15.
34. Scott LL, Hollier LM, Baum A, Jackson GL, Sanchez PJ, Wendel GD, Jr. Prevention of recurrent genital herpes at delivery using acyclovir suppression for herpes infection diagnosed prior to pregnancy. Am J Obstet Gynecol. 1998;178:S213.
35. Scott LL, Hollier LM, Jackson GL, Sanchez PJ, Baum A, Wendel GD, Jr. Acyclovir suppression to prevent cesarean delivery after first episode genital herpes simplex infection. Am J Obstet Gynecol. 1998; 178:812.
36. Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD, Jr. Acyclovir suppression to prevent cesarean delivery after first episode genital herpes. Obstet Gynecol. 1996;87: 73.
37. Brocklehurst P, Kinghorn G, Carney O, et al. A randomized placebo-controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynecol. 1998;105: 275-280.
38. Wittek AE, Yeager AS, Au DS, Hensleigh PA. Asymptomatic shedding of herpes simplex virus from the cervix and lesion site during pregnancy. Am J Dis Child. 1984; 138:439-442.
39. Stray-Pedersen B. Acyclovir in late pregnancy to prevent neonatal herpes simplex. Lancet. 1990;336:756-756.
40. Stray-Pedersen B. Genital Herpes in Pregnant Women in Oslo Norway. Presented at the European Society of Infectious Diseases in Obstetrics and Gynecology, Taormina-Giardini Naxos, Italy (June 14-19, 1992).
41. Kroon S, Whitley RJ. Management strategies in herpes: Can we improve management of perinatal HSV infection? In: Management Strategies in Herpes. Worthing, UK: PPS Europe Ltd., 1995:19-21.
42. Scott LL, Jackson GL, Sanchez PJ, Castaneda Y, Wendel GD, Jr. Prevention of caesarean section for recurrent genital herpes simplex virus (HSV) using acyclovir suppressive therapy. Scientific Program and Abstracts of the 40th Annual Meeting of the Society for Gynecologic Investigation, Toronto, Canada, March 31-April 3, 1993.
43. Haddad J, Langer B, Astruc D, Messer J, Lokiec F. Oral acyclovir and recurrent genital herpes during late pregnancy. Obstet Gynecol. 1993;82:102-104.
44. Scott LL, Dobson AT, Hollier LM, Little BB. Maternal acyclovir therapy delays mortality from disseminated neonatal herpes in a mouse model. Am J Obstet Gynecol. 1997;176:S37.
45. Scott LL, Dobson AT, Hollier LM, Little BB. Prevention of neonatal herpes with prophylactic acyclovir - a murine model. Am J Obstet Gynecol. 1997;176:S31.
46. Welle S, Blum MR, Doucette M. Pharmacokinetics of the acyclovir pro-drug valacyclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther. 1993;54: 595-605.
47. Kimberlin DF, Weller S, Andrews WW, et al. Valaciclovir pharmacokinetics in late pregnancy. Am J Obstet Gynecol. 1998; 178:812.
48. Vere Hodge RA, Perkins RM. Famciclovir and penciclovir. The mode of action of famciclovir including its conversion to penciclovir. Antiviral Chem Chemother. 1989; 4:67-84.
49. Thackray AM, Field HJ. Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model. Antimicrob Agents Chemother. 1996;40:846-851.
50. Thackray AM, Field HJ. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency. J Infect Dis. 1996; 173: 291-299.
51. Field HJ, Thackray AM. The effects of delayed-onset chemotherapy using famciclovir or valaciclovir in a murine immunosuppression model for HSV-1. Antiviral Chem Chemother. 1995:6:210-216.
52. Scott LL, Alexander JA. A cost comparison of acyclovir suppression versus no medical therapy for recurrent genital herpes in pregnancy. Am J Perinatol. 1998;15:57-62.
53. Randolph AG, Hartshorn RM, Washington AE. Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: A cost-effectiveness analysis. Obstet Gynecol. 1997;88:603-610.